精准外科时代的肝门部胆管癌治疗

Treatment of hilar cholangiocarcinoma in the era of precision surgery

  • 摘要: 肝门部胆管癌(HCCa)是一种严重威胁患者生命的胆道恶性肿瘤,肝胆根治性切除是患者获得长期生存的唯一途径,但其根治性手术率低,预后较差。笔者结合国内外相关研究进展和自身经验,针对精准外科时代HCCa外科治疗决策、治愈性肝胆切除中3D影像评估、手术方式设计和最大化肝实质保留问题进行探讨。

     

    Abstract: Hilar cholangiocarcinoma (HCCa) is a biliary malignancy that seriously affects the survival of patients. Radical resection is the only cure method for patients to achieve long-term survival. However, due to the low rate of radical resection, its prognosis is poor. In this article, surgical treatment strategies of HCCa in the precision surgery era, 3D image evaluation in the curative resection, surgical procedure decision and the preservation of liver parenchyma in the hepatic resection are discussed combined with the research progress at home and abroad.

     

/

返回文章
返回